Development of an index to define overall disease severity in IBD
BACKGROUND AND AIM: Disease activity for Crohn's disease (CD) and UC is typically defined based on symptoms at a moment in time, and ignores the long-term burden of disease. The aims of this study were to select the attributes determining overall disease severity, to rank the importance of and...
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
BMJ Publishing Group
2016
|
| _version_ | 1826306642478628864 |
|---|---|
| author | Siegel, C Whitman, C Spiegel, B Feagan, B Sands, B Loftus, E Panaccione, R D'Haens, G Bernstein, C Gearry, R Ng, S Mantzaris, G Sartor, B Silverberg, M Riddell, R Koutroubakis, I O'Morain, C Lakatos, P McGovern, D Halfvarson, J Reinisch, W Rogler, G Kruis, W Tysk, C Schreiber, S Danese, S Sandborn, W Griffiths, A Moum, B Gasche, C Pallone, F Travis, S Panes, J Colombel, J Hanauer, S Peyrin-Biroulet, L |
| author_facet | Siegel, C Whitman, C Spiegel, B Feagan, B Sands, B Loftus, E Panaccione, R D'Haens, G Bernstein, C Gearry, R Ng, S Mantzaris, G Sartor, B Silverberg, M Riddell, R Koutroubakis, I O'Morain, C Lakatos, P McGovern, D Halfvarson, J Reinisch, W Rogler, G Kruis, W Tysk, C Schreiber, S Danese, S Sandborn, W Griffiths, A Moum, B Gasche, C Pallone, F Travis, S Panes, J Colombel, J Hanauer, S Peyrin-Biroulet, L |
| author_sort | Siegel, C |
| collection | OXFORD |
| description | BACKGROUND AND AIM: Disease activity for Crohn's disease (CD) and UC is typically defined based on symptoms at a moment in time, and ignores the long-term burden of disease. The aims of this study were to select the attributes determining overall disease severity, to rank the importance of and to score these individual attributes for both CD and UC. METHODS: Using a modified Delphi panel, 14 members of the International Organization for the Study of Inflammatory Bowel Diseases (IOIBD) selected the most important attributes related to IBD. Eighteen IOIBD members then completed a statistical exercise (conjoint analysis) to create a relative ranking of these attributes. Adjusted utilities were developed by creating proportions for each level within an attribute. RESULTS: For CD, 15.8% of overall disease severity was attributed to the presence of mucosal lesions, 10.9% to history of a fistula, 9.7% to history of abscess and 7.4% to history of intestinal resection. For UC, 18.1% of overall disease severity was attributed to mucosal lesions, followed by 14.0% for impact on daily activities, 11.2% C reactive protein and 10.1% for prior experience with biologics. Overall disease severity indices were created on a 100-point scale by applying each attribute's average importance to the adjusted utilities. CONCLUSIONS: Based on specialist opinion, overall CD severity was associated more with intestinal damage, in contrast to overall UC disease severity, which was more dependent on symptoms and impact on daily life. Once validated, disease severity indices may provide a useful tool for consistent assessment of overall disease severity in patients with IBD. |
| first_indexed | 2024-03-07T06:51:03Z |
| format | Journal article |
| id | oxford-uuid:fc9213c6-6c8b-4fbc-b995-6c04fdeadaf0 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T06:51:03Z |
| publishDate | 2016 |
| publisher | BMJ Publishing Group |
| record_format | dspace |
| spelling | oxford-uuid:fc9213c6-6c8b-4fbc-b995-6c04fdeadaf02022-03-27T13:21:58ZDevelopment of an index to define overall disease severity in IBDJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:fc9213c6-6c8b-4fbc-b995-6c04fdeadaf0EnglishSymplectic Elements at OxfordBMJ Publishing Group2016Siegel, CWhitman, CSpiegel, BFeagan, BSands, BLoftus, EPanaccione, RD'Haens, GBernstein, CGearry, RNg, SMantzaris, GSartor, BSilverberg, MRiddell, RKoutroubakis, IO'Morain, CLakatos, PMcGovern, DHalfvarson, JReinisch, WRogler, GKruis, WTysk, CSchreiber, SDanese, SSandborn, WGriffiths, AMoum, BGasche, CPallone, FTravis, SPanes, JColombel, JHanauer, SPeyrin-Biroulet, LBACKGROUND AND AIM: Disease activity for Crohn's disease (CD) and UC is typically defined based on symptoms at a moment in time, and ignores the long-term burden of disease. The aims of this study were to select the attributes determining overall disease severity, to rank the importance of and to score these individual attributes for both CD and UC. METHODS: Using a modified Delphi panel, 14 members of the International Organization for the Study of Inflammatory Bowel Diseases (IOIBD) selected the most important attributes related to IBD. Eighteen IOIBD members then completed a statistical exercise (conjoint analysis) to create a relative ranking of these attributes. Adjusted utilities were developed by creating proportions for each level within an attribute. RESULTS: For CD, 15.8% of overall disease severity was attributed to the presence of mucosal lesions, 10.9% to history of a fistula, 9.7% to history of abscess and 7.4% to history of intestinal resection. For UC, 18.1% of overall disease severity was attributed to mucosal lesions, followed by 14.0% for impact on daily activities, 11.2% C reactive protein and 10.1% for prior experience with biologics. Overall disease severity indices were created on a 100-point scale by applying each attribute's average importance to the adjusted utilities. CONCLUSIONS: Based on specialist opinion, overall CD severity was associated more with intestinal damage, in contrast to overall UC disease severity, which was more dependent on symptoms and impact on daily life. Once validated, disease severity indices may provide a useful tool for consistent assessment of overall disease severity in patients with IBD. |
| spellingShingle | Siegel, C Whitman, C Spiegel, B Feagan, B Sands, B Loftus, E Panaccione, R D'Haens, G Bernstein, C Gearry, R Ng, S Mantzaris, G Sartor, B Silverberg, M Riddell, R Koutroubakis, I O'Morain, C Lakatos, P McGovern, D Halfvarson, J Reinisch, W Rogler, G Kruis, W Tysk, C Schreiber, S Danese, S Sandborn, W Griffiths, A Moum, B Gasche, C Pallone, F Travis, S Panes, J Colombel, J Hanauer, S Peyrin-Biroulet, L Development of an index to define overall disease severity in IBD |
| title | Development of an index to define overall disease severity in IBD |
| title_full | Development of an index to define overall disease severity in IBD |
| title_fullStr | Development of an index to define overall disease severity in IBD |
| title_full_unstemmed | Development of an index to define overall disease severity in IBD |
| title_short | Development of an index to define overall disease severity in IBD |
| title_sort | development of an index to define overall disease severity in ibd |
| work_keys_str_mv | AT siegelc developmentofanindextodefineoveralldiseaseseverityinibd AT whitmanc developmentofanindextodefineoveralldiseaseseverityinibd AT spiegelb developmentofanindextodefineoveralldiseaseseverityinibd AT feaganb developmentofanindextodefineoveralldiseaseseverityinibd AT sandsb developmentofanindextodefineoveralldiseaseseverityinibd AT loftuse developmentofanindextodefineoveralldiseaseseverityinibd AT panaccioner developmentofanindextodefineoveralldiseaseseverityinibd AT dhaensg developmentofanindextodefineoveralldiseaseseverityinibd AT bernsteinc developmentofanindextodefineoveralldiseaseseverityinibd AT gearryr developmentofanindextodefineoveralldiseaseseverityinibd AT ngs developmentofanindextodefineoveralldiseaseseverityinibd AT mantzarisg developmentofanindextodefineoveralldiseaseseverityinibd AT sartorb developmentofanindextodefineoveralldiseaseseverityinibd AT silverbergm developmentofanindextodefineoveralldiseaseseverityinibd AT riddellr developmentofanindextodefineoveralldiseaseseverityinibd AT koutroubakisi developmentofanindextodefineoveralldiseaseseverityinibd AT omorainc developmentofanindextodefineoveralldiseaseseverityinibd AT lakatosp developmentofanindextodefineoveralldiseaseseverityinibd AT mcgovernd developmentofanindextodefineoveralldiseaseseverityinibd AT halfvarsonj developmentofanindextodefineoveralldiseaseseverityinibd AT reinischw developmentofanindextodefineoveralldiseaseseverityinibd AT roglerg developmentofanindextodefineoveralldiseaseseverityinibd AT kruisw developmentofanindextodefineoveralldiseaseseverityinibd AT tyskc developmentofanindextodefineoveralldiseaseseverityinibd AT schreibers developmentofanindextodefineoveralldiseaseseverityinibd AT daneses developmentofanindextodefineoveralldiseaseseverityinibd AT sandbornw developmentofanindextodefineoveralldiseaseseverityinibd AT griffithsa developmentofanindextodefineoveralldiseaseseverityinibd AT moumb developmentofanindextodefineoveralldiseaseseverityinibd AT gaschec developmentofanindextodefineoveralldiseaseseverityinibd AT pallonef developmentofanindextodefineoveralldiseaseseverityinibd AT traviss developmentofanindextodefineoveralldiseaseseverityinibd AT panesj developmentofanindextodefineoveralldiseaseseverityinibd AT colombelj developmentofanindextodefineoveralldiseaseseverityinibd AT hanauers developmentofanindextodefineoveralldiseaseseverityinibd AT peyrinbirouletl developmentofanindextodefineoveralldiseaseseverityinibd |